Quetiapine Fumarate
NDC 16571-809, Quetiapine Fumarate, tablet, film coated, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-809
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091388
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-809 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- QUETIAPINE FUMARATE150 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-809-01 | 16571080901 | 100 TABLET, FILM COATED in 1 BOTTLE (16571-809-01) |
| 16571-809-10 | 16571080910 | 1000 TABLET, FILM COATED in 1 BOTTLE (16571-809-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/532c8ace-4cf5-4a08-bae7-2af8c41ffa3dNADAC price for package 16571080901
GET /v1/drugs/nadac/16571080901
Use it
Look up 16571-809 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-809 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-809. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.